Is rcd3 a breed-specific concern for Old English Sheepdogs?
Not particularly; it's best documented in a different breed, so its predictive value here is more limited.
Quick answer
Is rcd3 a breed-specific concern for Old English Sheepdogs?
Not particularly; it's best documented in a different breed, so its predictive value here is more limited.
PRA is the umbrella term; rcd3 is one specific, lab-identified gene variant underneath it, and knowing the difference changes what a genetic test result actually tells you.

Owners and breeders trying to make sense of a DNA panel result that flags rcd3, and anyone confused about why a genetic test would name a mutation that isn't the breed's own most prominently studied form.
This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.
Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.
PRA-rcd3 is one specific, named genetic mutation within the broader progressive retinal atrophy disease category, best documented and validated in a different breed than the Old English Sheepdog. A DNA panel may flag it as part of a broader multi-condition screen, but the result carries less predictive certainty here than it would in the breed where the mutation was originally characterized, making an actual eye exam the more meaningful follow-up.
This specific mutation isn't established as a common or well-documented cause of PRA in this breed. It may appear on a genetic panel as part of a broad multi-breed screen, but its relevance to this breed specifically remains uncertain compared to breeds where it's been directly studied.
This breed's documented health profile doesn't identify rcd3 as an established cause of retinal disease here; the mutation's characterization comes primarily from research in a different breed, meaning its presence or relevance in this breed's population is comparatively unclear.
There's no environmental driver relevant to this specific genetic marker, since it concerns an inherited mutation rather than an environmentally triggered condition; environmental factors are more relevant to supporting a dog's adaptation if vision loss from any PRA subtype does occur.
Talk to your vet about any positive or carrier rcd3 result, and separately, about any actual vision changes like night blindness, since a clinical exam and functional testing carry more weight for this breed than the genetic marker alone.
See all OLD English Sheepdog health problems, which breeds are prone to progressive retinal atrophy pra rcd3, or the full OLD English Sheepdog breed guide for temperament, exercise needs and ownership costs.
Genetic panel results are typically available within a couple of weeks of submitting a sample. Interpreting an unusual or breed-atypical result, like rcd3 in this breed, may take an additional conversation with a vet or geneticist to put in proper context.
Success looks like using a genetic panel result as one data point among several, paired with an actual eye exam, rather than treating an unvalidated marker as a definitive answer either way.
Genetic researchers have identified dozens of distinct mutations across different genes that all produce a similar end result, progressive retinal degeneration, but through different specific mechanisms in different breeds. Rcd3 specifically refers to a mutation affecting rod-cone development that was characterized and named in the breed population where it was first studied and validated. Commercial DNA panels often screen for a broad range of these named mutations across many breeds simultaneously as a cost-efficient package, which is why a panel run on an Old English Sheepdog might return a result for rcd3 even though this particular mutation's relevance and prevalence specifically in this breed isn't well established the way it is in the breed where it was originally characterized.
A genetic test result flagging rcd3 status, whether clear, carrier, or affected, is really only as useful as the validation behind it for your specific breed. For a breed where a mutation has been thoroughly studied and its correlation with actual disease confirmed, a result is highly predictive. For a mutation like rcd3 in a breed like this one, where that specific correlation isn't well established, a result is more of an interesting data point than a definitive answer, and it shouldn't be treated as equivalent to a diagnosis or ruled out entirely on its own. The most useful next step after any concerning panel result, regardless of which specific mutation it names, is a conversation with a veterinary ophthalmologist or geneticist who can put that result in proper context alongside an actual eye exam.

Lauren ran a broad genetic health panel on her Old English Sheepdog puppy Ash mostly out of general curiosity, and the results flagged Ash as a carrier for the rcd3 mutation. Concerned, Lauren brought the results to her vet, who explained that this particular marker's relevance to Ash's breed specifically wasn't well established, since it had been characterized mainly in a different breed's population. Rather than treating the carrier status as meaningful on its own, Lauren's vet recommended a baseline ophthalmology exam instead, which came back completely normal. Lauren kept the genetic result on file but based her actual monitoring plan on the clinical exam rather than the ambiguous marker.
Key takeaway: A genetic result that sounded alarming turned out to carry limited weight for Ash's specific breed, and getting an actual eye exam rather than reacting to the panel alone gave Lauren a far more meaningful answer.
Rcd3, or rod-cone dysplasia type 3, is one specific, named genetic mutation within the broader PRA disease category, identified and characterized primarily in a different breed than this one.
No, its correlation with actual disease is best established in the breed where it was originally characterized, not this one, which means a positive result here carries less predictive certainty than it would in that breed.
It's reasonable to include as part of a broader genetic panel, but interpret a result cautiously given the limited breed-specific validation, and follow up any concerning result with an actual veterinary ophthalmology exam.
PRA is the broad disease category describing retinal degeneration from many possible causes; rcd3 is one specific, named genetic mutation identified as one particular cause within that broader category.
No, a clear result for one specific mutation doesn't rule out other PRA-causing mutations that a panel may not test for, or that haven't yet been identified and characterized in this breed.
Commercial DNA panels covering multiple conditions, including various PRA subtypes, typically cost well under two hundred dollars and are increasingly accessible through mail-in cheek swab kits.
Discuss the result with your vet or a veterinary ophthalmologist, who can weigh it alongside an actual eye exam rather than treating the genetic result alone as a diagnosis, particularly given the limited validation of this specific marker in this breed.
Not particularly; it's best documented in a different breed, so its predictive value here is more limited.
PRA is the broad disease category; rcd3 is one specific, named genetic mutation identified as a cause within it.
No, it only rules out that one specific mutation, not other possible causes of retinal degeneration.
Typically well under two hundred dollars for a broad multi-condition DNA panel through a mail-in kit.
No, it should be discussed with a vet or ophthalmologist and paired with an actual eye exam rather than treated alone.
A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.
You get: Vet visit prep sheet
No spam. One-click unsubscribe. See our privacy policy.
Preview page 1 before you decide.





